Lanz, D.
University of London · Queen Mary University of London
2 papers on CoChatORCID 0000-0001-9879-3069
Most cited papers
- Verified
Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK
Borner, M., Koeberle, D., Von Moos, R., Saletti, P., Rauch, D., Hess, V., Trojan, A., Helbling, D., Pestalozzi, B., Caspar, C., et al. (2008) · Annals of Oncology
Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments
Cited by 124
- Verified
Pilot study of a cluster randomised trial of a guided e-learning health promotion intervention for managers based on management standards for the improvement of employee well-being and reduction of sickness absence: GEM Study
Stansfeld, S. A., Kerry, S., Chandola, T., Russell, J., Berney, L., Hounsome, N., Lanz, D., Costelloe, C., Smuk, M., & Bhui, K. (2015) · BMJ Open
Workplace Health and Well-beingDigital Mental Health Interventions
Cited by 53
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free